Sands Capital Life Sciences Pulse Fund II, L.P.
10% Owner
Latest Insider Transactions
1 transactions (past 365 days)
| 2025-11-24 | 2025-11-21 | IKT Inhibikase Therapeutics, Inc. | 10% Owner | Purchase | 2,068,965 | $1.45 | $2,999,999 |
IKT
10% Owner
Purchase
$3M
2,068,965 shares @ $1.45
Filed 2025-11-24Trade 2025-11-21
Inhibikase Therapeutics, Inc.